The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
Publication|Videos|December 18, 2023
Adaptable Formulation Development Strategies for Today with a Focus on Tomorrow
Author(s)Serán
Wesley Tatum, PhD (Principal Engineer, Process & Product Development, Serán Bioscience) shares insights surrounding formulation and process development that focus on the future of the industry.
At the 2023 American Association of Pharmaceutical Scientists (AAPS) conference, Pharmaceutical Technology spoke with Serán's Wesley Tatum, PhD, about formulation strategies that consider the future of the industry. Learn more about:
- Leveraging expertise in material science and particle engineering. Serán addresses the industry’s most challenging problem statements in drug development.
- How a partnership philosophy that emphasizes creativity and collaboration enables rapid development of advanceable formulations and processes with minimal material.
- Identifying the best strategy and formulation technology for each program’s unique considerations and needs.
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.